 BetterLife Pharma Inc CSE:BETR, OTCQB:BETRF announced that it has closed a financing designed to advance its clinical and preclinical studies. The non-brokered private placement included 3,160,000 shares at a price of US0.15 per share for gross proceeds of US474,000. 